Back to search results

A Study of DZD8586 Combination in CLL/SLL (TAI-SHAN10)

Abroad (travel likely)RecruitingPHASE2

Conditions

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Anhui Provincial Cancer Hospital, Hefei, Anhui, China

    Ding

  • Peking University Third Hospital, Beijing, Beijing Municipality, China

    Jing

  • Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong, China

    Li

  • Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

    Guo

  • Henan Cancer Hospital, Zhengzhou, Henan, China

    Zhou

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

    Fang

  • Yichang Central People's Hospital, Yichang, Hubei, China

    Cai

  • Hunan Cancer Hospital, Changsha, Hunan, China

    Zhou

  • The First People's Hospital of Changzhou, Changzhou, Jiangsu, China

    Gu

  • Affiliated Hospital of Nantong University, Nantong, Jiangsu, China

    Shi

  • The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

    Li

  • The First Bethune Hospital of Jilin University, Changchun, Jilin, China

    Bai

  • Shengjing Hospital of China Medical University, Shenyang, Liaoning, China

    Yang

  • West China Hospital of Sichuan University, Chengdu, Sichuan, China

    Niu

  • The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

    Yu
Study leads

  • Niu

    Principal Investigator

    West China Hospital

View source on ClinicalTrials.gov(opens in a new tab)